Russia says it’s delivering a medication against COVID-19, Avifavir, to 15 countries. Kirill Dmitriev, Head, Russian Direct Investment Fund (RDIF), disclosed this to Russia-24 broadcaster in an interview.
The RDIF participated in the process of the Avifavir coronavirus remedial initiative as experts intensified efforts in the search for a solution.
“We can boast great achievements in this area, as the medication has been delivered to over 15 countries,” Dmitriev said.
“This is really important, as there are in fact only two international antiviral drugs that are delivered to a certain number of countries: the United States’ Remdesivir and the Russian Avifavir. Ninety per cent of the produced Remdesivir have been purchased by the U.S. So, it is no surprise that 15 countries purchase our medication”.
Earlier on Monday, Kromis — a joint venture of the RDIF and the ChemRar pharmaceutical company — announced it had reached agreement on Avifavir deliveries to South Africa and seven countries in Latin America.
Avifavir received a registration certificate of the Russian Ministry of Health in late May, becoming the world’s first favipiravir-based drug approved for the treatment of COVID-19.